Group One Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Group One Trading’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-470	Closed	-$7.62K	–	8511
2023 Q3	$10.2K	Buy	470 +171	+57%	+$5.48K	﹤0.01%	6325
2023 Q2	$11.5K	Sell	299 -1,014	-77%	-$35.8K	﹤0.01%	6316
2023 Q1	$36.4K	Buy	1,313 +1,169	+812%	+$39.6K	﹤0.01%	5089
2022 Q4	$4.72K	Buy	+144	New	+$10.5K	﹤0.01%	6365
2022 Q3	–	Sell	-37	Closed	-$6.66K	–	8559
2022 Q2	$6K	Sell	37 -154	-81%	-$32.5K	﹤0.01%	7069
2022 Q1	$55K	Buy	+191	New	+$72.5K	﹤0.01%	6028
2021 Q4	–	Sell	-340	Closed	-$244K	–	9082
2021 Q3	$129K	Buy	340 +227	+201%	+$97.3K	﹤0.01%	5649
2021 Q2	$100K	Buy	113 +107	+1,783%	+$81.8K	﹤0.01%	5960
2021 Q1	$7K	Buy	+6	New	+$8.27K	﹤0.01%	7182

Group One Trading's BIOR Position: Q4 2023 in Review

Group One Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2023, closing a stake of 470 shares — an estimated $7.62K sold.

Group One Trading first reported a position in BIOR in Q1 2021 and held it in 9 quarters. The position peaked at $129K in Q3 2021. 29 funds tracked by Wall St. Rank hold BIOR as of Q4 2023.

Group One Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 470 Biora Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $7.62K.
Group One Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Group One Trading's Biora Therapeutics, Inc. Common Stock position peaked at $129K in Q3 2021.
29 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.